Feline hepatitis: Pathogenesis, clinical aspects, diagnosis, and management
Abstract
The feline liver plays a central defensive role between the gastrointestinal system and the systemic circulation. Its unique positioning and dual blood supply expose it to a wide variety of infectious agents, toxins, and metabolic by products. Although the liver possesses strong detoxifying and immunological capabilities, several conditions can impair these defences, making cats vulnerable to hepatic inflammation. Kupffer cells-specialized hepatic macrophages account for nearly a third of non-parenchymal liver cells and form a critical line of immune protection.However, this protection can be compromised by hypovolemia, ischemic injury, Cholestasis, Chronic liver disease, Portal hypertension, Immune dysfunction, Endotoxemia, and Structural abnormalities in the hepatic vasculature. These conditions increase susceptibility to invading microorganisms, systemic pathogens, and locally produced toxins.
Full Text
Tables and figures are in the full-text PDF.
Introduction Etiology
Hepatitis in cats may arise from bacterial, fungal, protozoal, viral, parasitic, or non-infectious (toxic) origins. Because clinical presentations often overlap, determining the exact cause requires careful diagnostic assessment.
Bacterial Infections Bacterial causes are commonly associated with cholangitis or cholangiohepatitis. Frequent organisms include: Escherichia coli, Enterococcus spp. Bacteroides spp. Streptococcus spp. Clostridium spp. Helicobacter spp. Special Cases: Tyzzer's Disease (Clostridium piliforme) causes multifocal hepatic necrosis in young or immunocompromised animals.
Mycobacterial Infections: Cats may develop localized or systemic disease due to various mycobacteria. Key species: Mycobacterium bovis, acquired through ingestion of contaminated raw meat or wildlife exposure, Mycobacterium lepraemurium associated with cutaneous lesions, Mycobacterium visibilis, may cause widespread granulomatous inflammation, Mycobacterium avium complex, opportunistic organisms causing disseminated disease in immunosuppressed cats. Affected cats often display combinations of: Skin nodules, Lymphadenopathy, Hepatosplenomegaly, Granulomatous inflammation in multiple organs Fungal Infections: Cats may develop hepatic involvement as part of systemic mycoses. Immunohistochemistry can be employed to distinguish among these organisms. Chronic hepatitis is comparatively uncommon in cats. Cirrhosis is rare, and when diffuse hepatic fibrosis occurs, it most often reflects porto-portal bridging fibrosis associated with chronic biliary disease.
Clinical Signs Bacterial Infections
Clinical signs commonly include generalized lethargy, ulcerations of the tongue or oral mucosa, enlargement of regional or systemic lymph nodes, and increased liver and spleen size. Affected animals may show marked leukopenia, often with pronounced toxic changes in neutrophils. Hyperbilirubinemia and bilirubinuria are frequently observed as the disease progresses.
Mycobacterial Infections
Cats with mycobacterial disease often develop a widespread granulomatous condition that may initially present as diffuse skin lesions but can disseminate to multiple internal organs. Clinical manifestations vary depending on the organs in which granulomas form.
Although many cats infected with T. gondii may not appear ill, some develop clinical disease. Signs can include fever, reduced appetite, weight loss, and lethargy. Respiratory involvement may lead to pneumonia and difficulty breathing. Ocular inflammation, such as uveitis or retinitis, is possible. Liver involvement may produce hepatitis and jaundice.
Viral Infections
Clinical presentation often reflects the organ systems targeted by the virus, such as the kidneys, liver, gastrointestinal tract, or central nervous system. Some signs are also related to fluid shifts or vascular injury. Abnormal liver enzyme values may occur secondary to hepatitis, hepatic lipidosis, or the effects of vasculitis, hemolysis, or hypoxia. Hyperbilirubinemia is common and frequently results from hepatic vascular injury.
Parasitic Infections
Cats with significant parasitic burdens may develop a chronic, progressively worsening illness marked by fever, lethargy, abdominal enlargement, and hepatomegaly. Jaundice and severe weight loss can develop due to reduced appetite, vomiting, and mucous diarrhea. Heavy fluke infections can be fatal. Clinical signs typically begin 7-16 weeks after exposure, though eosinophilia may develop as early as 3-14 weeks and persist. Liver enzymes may change, with ALT and AST commonly increasing, while ALP may be normal or only mildly elevated. Hyperbilirubinemia can appear within 7-16 weeks of infection.
Non-Infectious Causes
Toxic or metabolic liver injury may result in hepatocellular swelling, fatty change, and necrosis, which often follow a characteristic zonal pattern (centrolobular, periportal, midzonal, or widespread). Additional features may include cholestasis, inflammatory responses, and varying degrees of fibrosis.
Diagnosis Bacterial Infections
Detection typically relies on identifying microscopic agglutinating antibodies, which is the most commonly used diagnostic approach. Indirect fluorescent antibody assays may also support diagnosis.
Fungal and Protozoal Infections
Diagnosis may involve cytological evaluation, serologic testing, and, in some cases, assessing the patient's response to treatment.
Viral Infections
A definitive diagnosis usually requires histopathological examination, supported by clinical history, physical findings, and laboratory data. Newer PCR-based tests can aid in confirming infections such as FIP.
Parasitic Infections
Early detection can be challenging. Diagnosis becomes more straightforward once parasite eggs or stages are identified, particularly in bile samples.
Non-Infectious Conditions
These disorders are generally diagnosed using the patient's clinical history and microscopic evaluation of liver tissue to identify characteristic histologic changes.
General Diagnostic Workup
A comprehensive evaluation may include a complete blood count, urinalysis, electrolyte profile, and biochemical testing. Imaging techniques such as ultrasound and radiography help assess liver architecture, and a biopsy may be collected for more detailed analysis.
Advanced Diagnostic Capabilities
Modern diagnostic facilities use sophisticated laboratory methods and imaging technologies to accurately identify liver diseases in pets and guide appropriate treatment plans.
Treatment Bacterial and Mycobacterial Infections
Although aminoglycosides are commonly used in human medicine, small-animal treatment more often relies on drugs such as doxycycline, chloramphenicol, or fluoroquinolones. These medications can be effective, but recurrence of clinical signs is unfortunately not uncommon.
Fungal Infections
Systemic fungal diseases are typically managed with antifungal agents from the triazole group, most notably itraconazole and fluconazole. In more severe cases, amphotericin B may be incorporated into the treatment plan.
Protozoal Infections
Therapies such as diminazene or imidocarb have shown beneficial outcomes in some protozoal diseases. Clindamycin is also widely used and can be effective in treating certain protozoal infections.
Viral Infections
Management of viral liver disease is mainly supportive, focusing on controlling symptoms and maintaining organ function rather than eliminating the virus itself.
Parasitic Infections
Praziquantel is typically effective for treating liver fluke infestations and infections caused by Platynosomum concinnum.
Non-Infectious Conditions
For toxic or metabolic causes of liver injury, removing or stopping exposure to the offending agent is the first step. Subsequent treatment is tailored to the animal's clinical signs and the specific pathological changes present.
Prevention
Cats should receive a diet that includes easily digestible carbohydrates, high-quality sources of fat, and restricted sodium levels. This nutritional approach helps minimize further liver injury and supports improved hepatic function.
Conflict of Interest Not available
Financial Support
References
- Bowman DD. Georgis' Parasitology for Veterinarians. 11 th Ed. 2020.
- Center SA. Diseases of the liver. In: Nelson RE, Couto CG, editors. Small Animal Internal Medicine. 5th ed. 2013, p. 542-590.
- Cowell RL, Tyler RD, Meinkoth JH, DeNicola DB. Diagnostic Cytology and Hematology of the Dog and Cat. 4 th Ed; 2015.
- Cullen JM, Stalker MJ, McKenzie CA. Liver and biliary system. In: Jubb D, Kennedy P, Palmer N, editors. Jubb, Kennedy, and Palmer's Pathology of Domestic Animals. 6 th Ed. Vol. 2. 2022, p. 367-421.
- Dubey JP. Toxoplasmosis of animals and humans. 2 nd Ed. CRC Press; 2010.
- Foster JD, Twedt DC. Biliary disease in cats. J Feline Med Surg. 2016;18(1):4-16.
- Greene CE. Infectious Diseases of the Dog and Cat. 4 th Ed.; 2012.
- Greene CE, Gunn-Moore D. Cytauxzoonosis and other protozoal infections. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 2012, p. 795-804.
- Hartmann K. Clinical aspects of feline infectious peritonitis. Vet Clin North Am Small Anim Pract. 2017;47(5):813-829.
- Weiss DJ, Wardrop KJ. Schalm's Veterinary Hematology. 6 th Ed. Wiley-Blackwell; 2010.
- Willard MD, Twedt DC. Gastrointestinal, pancreatic, and hepatic disorders. In: Ettinger MA, Feldman EC, Côté E, editors. Textbook of Veterinary Internal Medicine. 8 th Ed. 2018, p. 1612-1685.
How this paper connects to the literature. Drag to explore, click any node to open that paper.